Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Pharmaceutical Policy in Countries with Developing Healthcare Systems (eBook)

Zaheer-Ud-Din Babar (Herausgeber)

eBook Download: PDF
2017 | 1st ed. 2017
XII, 430 Seiten
Springer International Publishing (Verlag)
978-3-319-51673-8 (ISBN)

Lese- und Medienproben

Pharmaceutical Policy in Countries with Developing Healthcare Systems -
Systemvoraussetzungen
149,79 inkl. MwSt
(CHF 146,30)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.



Dr. Zaheer-Ud-Din Babar is globally recognized for his research in pharmaceutical policy and practice, including quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. He was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand (2011-2015). A pharmacist by training, and with a PhD in pharmacy practice, Dr. Babar is the recipient of the prestigious 'Research Excellence Award' from the University of Auckland. Dr. Babar has presented invited lectures at Boston University School of Public Health, Harvard Medical School, Austrian Health Institute and at the Universities of Reading and Kingston.

He has published over 100 papers including in high impact journals such as PLoS Medicine and The Lancet Oncology. Dr. Babar has acted as an advisor for the World Health Organisation, Health Action International, International Union Against Tuberculosis and Lung Disease, World Bank, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand. His other books include work on pharmaceutical prices in the 21st century, pharmacy practice research methods and on economic evaluation of pharmacy services. Dr. Babar is also the Editor-in-Chief of the BMC Journal of Pharmaceutical Policy and Practice. He can be contacted at z.babar@auckland.ac.nz.

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the Department of Pharmacy, University of Huddersfield, United Kingdom.He is globally recognized for his research in pharmaceutical policy and practice, including the quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. Previously he was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a Ph.D. in pharmacy practice, Dr. Babar is the recipient of prestigious “Research Excellence Award” from the University of Auckland.He has active research collaborations and linkages in over 30 countries including in World’s leading Universities such as Boston University School of Public Health, Harvard Medical School, Austrian Health Institute, University of Auckland, Monash University and at the University of Sydney. He has published over 150 papers, book chapters, conference papers including in high impact journals such as PLoS Medicine and in Lancet Oncology. Dr. Babar has acted as an advisor for World Health Organization, Health Action International, the International Union Against Tuberculosis and Lung Disease, World Bank, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand.His recent work includes a number of high-quality books including "Economic evaluation of pharmacy services", ”Pharmaceutical prices in 21st century”, “ Pharmacy Practice Research Methods” and “Pharmaceutical policies in countries with developing healthcare systems. Published by Elsevier and Adis/Springer, the work is used in curriculum design, policy development and for referral all around the globe.He is the Editor- in- Chief of Encyclopedia of Pharmacy Practice and Clinical Pharmacy, which is due to be published by Elsevier in early 2019.The Encyclopedia aims to cover multiple stream and domains including pharmacy practice, sociobehavioural, and administrative pharmacy, pharmacoepidemiology, clinical pharmacy and therapeutics and issues related to pharmacy education, professional standards, and workforce. Professor Babar is also the Editor-in-Chief of BMC Journal of Pharmaceutical Policy and Practice and can be contacted at z.babar@hud.ac.uk

1. Introduction.- Section I: Low and Lower Middle Income Countries.- 2. Pharmaceutical Policy in the East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania.- 3. Pharmaceutical Policy in Pakistan.- 4. Pharmaceutical Policy in Philippines.- 5. Pharmaceutical Policy in Vietnam.- Section II: Upper Middle Income Countries.- 6. Pharmaceutical Policy in Argentina.- 7. Pharmaceutical Policy in Brazil.- 8. Pharmaceutical Policy In Bulgaria.- 9. Pharmaceutical Policy in China.- 10. Pharmaceutical Policy in Colombia.- 11. Pharmaceutical Policy in Ecuador.- 12. Pharmaceutical Policy in Jordan.- 13. Pharmaceutical Policy in Russia.- 14. Pharmaceutical Policy in South Africa.- Section III: High Income Countries.- 15. Pharmaceutical Policy in Poland.- 16. Pharmaceutical Policy in Saudi Arabia.- 17. Pharmaceutical Policy in Trinidad and Tobago.- 18. Pharmaceutical Policy in United Arab Emirates.- Section IV: Further Perspectives.- 19. ‘Repurposing’ Medicines: a Case for Low- and Middle-Income Countries with Developing Healthcare Systems.- 20. Pharmaceutical Policy in Countries with Developing Healthcare Systems: Synthesis of Country Case Studies.

Erscheint lt. Verlag 27.3.2017
Zusatzinfo XII, 430 p. 36 illus., 33 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Pharmazie
Technik
Schlagworte Access to Medicines • Low income countries • Medicines Regulation • Medicines Use • Middle income countries • Pharmaceutical Health Services • Pharmacoeconomics • pharmacovigilance • Pharmacy practice
ISBN-10 3-319-51673-6 / 3319516736
ISBN-13 978-3-319-51673-8 / 9783319516738
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 6,8 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Grundlagen und Fallbeispiele für das Medikationsmanagement

von Ina Richling; Ina Richling

eBook Download (2023)
Deutscher Apotheker Verlag
CHF 46,90